NYSE:S
NYSE:SSoftware

SentinelOne (NYSE:S) Unveils Purple AI 'Athena' To Revolutionize Cybersecurity With Advanced AI Capabilities

The recent 14% price increase for SentinelOne (NYSE:S) over the last week coincided with the unveiling of their next-gen Purple AI 'Athena' at RSA Conference 2025, featuring enhanced security capabilities that likely bolstered investor confidence. Additionally, a strategic collaboration with Nord Security aimed at enhancing cybersecurity for SMBs may have positively impacted sentiment. While these developments occurred amidst an overall market rise, the company's innovations in AI and...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GlobalFoundries (NasdaqGS:GFS) Sees 12% Rise Following Merger Speculation Last Week

GlobalFoundries (NasdaqGS:GFS) has been in the spotlight following rumors of a potential merger with United Microelectronics Corporation (UMC), aiming to create a formidable U.S.-based semiconductor entity. This speculation may have influenced the company's notable 12% price increase last week. While the broader market has risen 7% over the past week, driven by strong earnings and an optimistic outlook on tariffs, the merger discussions likely bolstered GlobalFoundries' performance. The...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis

AbbVie (NYSE:ABBV) recently secured FDA approval for RINVOQ to treat giant cell arteritis, which alongside a biologics license application for TrenibotE, underscored the company's focus on innovation. Despite a 13% rise in its share price over the past week, AbbVie's gains were in line with the broader market's 7% climb, suggesting these product developments and positive sales growth added weight to the general upward momentum. Meanwhile, the broader market's reaction to strong earnings...